Health security strategy: strengthening Europe’s pharma industry base
A resilient and dynamic ecosystem for healthcare innovation is key to strengthening the European Union. A comprehensive strategy brings patient
Read more
Industry
Enhancing the resilience and the competitiveness of the pharma supply chains to secure access to critical medicines and other medical countermeasures
When the COVID-19 pandemic hit, countries around the globe were caught off guard. In Europe, each country initially responded on
Read more
The patient at the center of all health policies
In the wake of the global COVID-19 crisis, Europe stands at a critical juncture in shaping its health policies and
Read more
Building a Strong European Health Union: Blazing a trail in the European pharmaceutical sector
The start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global
Read more
A critical medicines act for Europe
Introduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read more
Rethinking the EU general pharmaceutical legislation for a competitive, more resilient and healthier Europe
As discussions surrounding the revision of the EU pharmaceutical legislation take place, two fundamental questions come to the forefront: how
Read more
New EU pharmaceuticals rules in a strong European Health Union
Since 2020, the COVID pandemic altered every part of our lives, our societies, and our economies. It caught the world
Read more
The lessons EU learned from the pandemic towards a better prepared and resilient pharmaceutical system
The COVID-19 crisis has pushed health higher on the agenda of the European Union, but also on the list of
Read more